Zimbabwe has rejected a significant US healthcare agreement valued at 367 million US dollars (272 million pounds) spanning five years because of the United States' request for confidential biological samples.
This move was revealed following a government memo from December was leaked, which showed President Emmerson Mnangagwa believed the agreement was "unbalanced".
An official representative later stated that the US was demanding access to health data for scientific study and commercial purposes while refused to share the benefits from any future treatments.
"We are forced to start the difficult and regrettable process of scaling back our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the US had furnished more than $1.9bn in health funding to Zimbabwe during the past two decades.
A medical body in Zimbabwe has urged continued dialogue to secure a deal acceptable to both sides so the nation's critical HIV programme can be sustained.
Broader Context
Zimbabwe's decision comes after a similar case in Kenya, where a high court halted a similar deal with the US after legal challenges were raised about the security of citizens' medical information.
After returning to the presidency last year, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
The agency had managed assistance for the American government, but Trump stated its expenditure was "wasteful" and his administration was seeking direct bilateral deals to enhance openness and responsibility.
Based on statements, 16 nations in Africa have to date agreed to these new health pacts, representing more than $18.3bn in committed funds.
Specifics of the Rejected Agreement
The funds for Zimbabwe was intended to funded "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this collaboration would have delivered extraordinary advantages for Zimbabwean communities, especially the 1.2 million currently receiving antiretroviral therapy through US-supported initiatives," the Ambassador commented.
However, government spokesperson Nick Mangwana said the proposed deal was "asymmetrical".
"Our nation was requested to surrender its genetic material and health information for a long time, without any equivalent promise of benefiting from any medical innovations – such as new medicines or tests – that could be developed from that shared data," Mangwana explained.
"Effectively, our nation would provide the raw materials for medical research with no assurance that the resulting innovations would be available to our population should a new health crisis arise."
Sovereignty and International Frameworks
He also pointed out that the US's withdrawal from the global health body and its pursuit of one-on-one deals were undermining frameworks previously established through the international health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing system designed to deal with potential pandemics.
"This framework is designed to guarantee that when a country provides its information, the resulting advantages – including medicines and cures – are distributed fairly, not commercialised exclusively by those with the funds to develop them."
Zimbabwe's reservations regarding the US deal "must not be interpreted as opposition to America," he added.
"We encourage ongoing discussions with our US partners on how subsequent collaboration could be arranged in a way that honours the independence and interests of each country."
Medical Community Response
Medical experts said it understood the official position, but urged that negotiations must proceed considering much of the country's Aids initiatives depended on foreign aid.
"If technical issues exist, such as those relating to information security or implementation frameworks, these can often be addressed via technical clarification and mutually agreed protections," the group added.
This impasse emphasises the complex debate between receiving much-needed international aid and protecting a country's data in an increasingly interconnected world.